Jump to main content
Jump to site search

Issue 3, 2019
Previous Article Next Article

Using 2-aminobenzimidazole derivatives to inhibit Mycobacterium smegmatis biofilm formation

Author affiliations

Abstract

Biofilm formation by mycobacteria can lead to enhanced antibiotic tolerance. Herein, we report on the identification of a series of 2-aminobenzimidazole (2-ABI) derivatives that potently inhibit biofilm formation by Mycobacterium smegmatis.

Graphical abstract: Using 2-aminobenzimidazole derivatives to inhibit Mycobacterium smegmatis biofilm formation

Back to tab navigation

Supplementary files

Publication details

The article was received on 14 Jan 2019, accepted on 07 Feb 2019 and first published on 12 Feb 2019


Article type: Research Article
DOI: 10.1039/C9MD00025A
Citation: Med. Chem. Commun., 2019,10, 456-459

  •   Request permissions

    Using 2-aminobenzimidazole derivatives to inhibit Mycobacterium smegmatis biofilm formation

    T. V. Nguyen, M. T. Peszko, R. J. Melander and C. Melander, Med. Chem. Commun., 2019, 10, 456
    DOI: 10.1039/C9MD00025A

Search articles by author

Spotlight

Advertisements